Chronic Activation of Wild-Type Epidermal Growth Factor Receptor and Loss of Cdkn2a Cause Mouse Glioblastoma Formation
Glioblastoma multiforme (GBM) is characterized by overexpression of epidermal growth factor receptor (EGFR) and loss of the tumor suppressors Ink4a/Arf. Efforts at modeling GBM using wild-type EGFR in mice have proven unsuccessful. Here, we present a unique mouse model of wild-type EGFR-driven gliom...
Main Authors: | Whittaker, Charles A., Charest, Alain, Acquaviva, Jaime, Jun, Hyun Jung, Lessard, Julie, Ruiz, Rolando, Zhu, Haihao, Donovan, Melissa, Woolfenden, Steve, Boskovitz, Abraham, Raval, Ami, Bronson, Roderick T., Pfannl, Rolf, Housman, David E |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
American Association for Cancer Research
2014
|
Online Access: | http://hdl.handle.net/1721.1/84529 https://orcid.org/0000-0001-5016-0756 |
Similar Items
-
Acquired MET expression confers resistance to EGFR inhibition in a mouse model of glioblastoma multiforme
by: Jun, Hyun Jung, et al.
Published: (2014) -
The Oncogenic Lung Cancer Fusion Kinase CD74-ROS Activates a Novel Invasiveness Pathway through E-Syt1 Phosphorylation
by: Johnson, Hannah, et al.
Published: (2014) -
Genome-wide analyses implicate 33 loci in heritable dog osteosarcoma, including regulatory variants near CDKN2A/B
by: Karlsson, Elinor K., et al.
Published: (2014) -
Topography of transcriptionally active chromatin in glioblastoma
by: Xu, Liang, et al.
Published: (2021) -
Mechanism of acquired temozolomide resistance in glioblastoma
by: McFaline-Figueroa, José L
Published: (2014)